On ECHEMI
Home > Drugs > Congestive heart failure
Congestive heart failure
Congestive heart failure (CHF) refers to a pathological state in which cardiac output is insufficient to maintain tissue metabolism due to cardiac systolic and/or diastolic dysfunction in the presence of adequate venous blood return.
  • Site of disease:

    Heart blood vessels lungs
  • Infectious :

    Not contagious
  • Frequent population:

    Patients with pre-existing cardiovascular disease
  • Related symptoms:

    Pink foamy sputum Orthopnea Third heart sound gallop rhythm Increased cardiac output Myocardial nutritional disorder
  • Concurrent disease:

Related Drugs
Isosorbide mononitrate dispersible tablets
Indication: Long-term treatment of coronary heart disease and prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics to treat chronic congestive heart failure.
Manufacturer:

Lunan BETTER Pharmaceutical Co., Ltd.

Isosorbide dinitrate and sodium chloride injection
Indication: For the treatment of angina pectoris and congestive heart failure.
Manufacturer:

Echo Group Jiangxi Dongya Pharmaceutical Co., Ltd.

Isosorbide dinitrate and sodium chloride injection
Indication: For the treatment of angina pectoris and congestive heart failure.
Manufacturer:

Echo Group Jiangxi Dongya Pharmaceutical Co., Ltd.

Isosorbide dinitrate tablets
Indication: Long-term treatment of coronary heart disease; prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics to treat chronic congestive heart failure.
Manufacturer:

Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.

Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:

Wanbangde Pharmaceutical Group Co., Ltd.

Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:

Chongqing Qingyang Pharmaceutical Co., Ltd.

Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:

Beijing Yanjing Pharmaceutical Co., Ltd.

Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:

CSPC OUYI Pharmaceutical Co., Ltd.

Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:

CSPC OUYI Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.